Tower View Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Tower View Wealth Management's AMGN Position: Q2 2026 in Review
Tower View Wealth Management reduced its Amgen (AMGN) stake by 77% in Q2 2026, selling an estimated $21.6K and leaving 19 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #168.
Tower View Wealth Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $28.8K in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Tower View Wealth Management held 19 shares of Amgen worth $6.88K as of Q2 2026.
- Tower View Wealth Management sold 63 Amgen shares in Q2 2026, an estimated $21.6K.
- Amgen made up ﹤0.01% of Tower View Wealth Management's portfolio in Q2 2026, its #168 holding.
- Tower View Wealth Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
- Tower View Wealth Management's Amgen position peaked at $28.8K in Q1 2026.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.